KMTS
KMTS
NASDAQ · Health Care

Kestra Medical Technologies

$24.43
+0.08 (+0.33%)
As of Sep 20, 10:11 PM ET ·
Financial Highlights (FY 2026)
Revenue
101.91M
Net Income
-140,998,132
Gross Margin
51.4%
Profit Margin
-138.4%
Rev Growth
+131.9%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 51.4% 51.6% 51.6% 51.6%
Operating Margin -141.6% 19.2% 19.0% 18.4%
Profit Margin -138.4% 13.2% 16.0% 14.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 101.91M 467.86M 451.21M 384.70M
Gross Profit 52.35M 241.42M 232.82M 198.50M
Operating Income -144,349,476 89.79M 85.79M 70.89M
Net Income -140,998,132 61.58M 72.02M 57.24M
Gross Margin 51.4% 51.6% 51.6% 51.6%
Operating Margin -141.6% 19.2% 19.0% 18.4%
Profit Margin -138.4% 13.2% 16.0% 14.9%
Rev Growth +131.9% +24.3% -1.3% +10.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 100.06M 164.83M 164.09M 153.25M
Total Equity 609.02M 1.08B 950.20M 957.14M
D/E Ratio 0.16 0.15 0.17 0.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -135,024,766 118.92M 127.55M 105.65M
Free Cash Flow 46.82M 46.49M 55.42M